Randomised Phase III trials with large patient groups

We conduct randomised Phase III trials with large populations and a broad spectrum of therapy areas.

Our model has been crafted to support our sponsors’ needs in the latter stages of drug development.

x

Examples of Richmond’s accelerated patient recruitment

Number one recruitment site out of 83 centres for a study involving patients with Transthyretin Amyloidosis with Cardiomyopathy. 64 patients were recruited within three months.

Richmond recruited 10% of the total patient volunteers needed for a global heart failure trial in just two months.

We are experts in conducting randomised Phase III clinical trials.

Our specialist clinical team has experience in conducting clinical trials with a broad spectrum of patient groups with common and rare diseases.

Get in touch today

Why choose Richmond Pharmacology for Phase III Clinical Trials

TAP OR CLICK A BLOCK BELOW TO LEARN MORE

Single centre studies

We are equipped to deliver single centre studies for early phase patient trials.

Read more +

Multi-disciplined teams

We have access to specialist consultants, professors and medical practitioners through our academic and medical partnerships.

Read more +

Hospital-style setting

Our multi-disciplinary team operate in a hospital-style setting which facilitates efficient, safe trial management.

Read more +

We maintain a 100% retention rate for patients in your study thanks to the engaged and responsive volunteer recruitment project managers.

Latest news

Clinical trials: how taking the pills can pay those bills.

April 20, 2022
The Guardian references Richmond Pharmacology in feature on reimbursement for clinical trial volunteers
Read more

Clinical trials and the patient perspective

May 6, 2022
Successful recruitment and retention of patients - an essential element to delivering clinical studies on time.
Read more

Events

The Future of Healthcare - March 2022

13:30 – 16:00, 22nd March 2022
Discover the intricacies of assessing abnormal liver functions in clinical trial volunteers and gain insights from the latest drug development trials using RNAi therapeutics.
View event